These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24103246)

  • 1. [Endocrinological outcome in children and adolescents survivors of central nervous system tumours after a 5 year follow-up].
    Güemes Hidalgo M; Muñoz Calvo MT; Fuente Blanco L; Villalba Castaño C; Martos Moreno GA; Argente J
    An Pediatr (Barc); 2014 Jun; 80(6):357-64. PubMed ID: 24103246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late complications in childhood central nervous system tumour survivors.
    Anderson NE
    Curr Opin Neurol; 2003 Dec; 16(6):677-83. PubMed ID: 14624076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamo-pituitary-adrenal axis integrity after cranial irradiation for childhood posterior fossa tumours.
    Spoudeas HA; Charmandari E; Brook CG
    Med Pediatr Oncol; 2003 Apr; 40(4):224-9. PubMed ID: 12555249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of early hypothalamic-pituitary damage in childhood brain tumor survivors: need for standardized follow-up programs.
    Clement SC; Meeteren AY; Kremer LC; van Trotsenburg AS; Caron HN; van Santen HM
    Pediatr Blood Cancer; 2014 Dec; 61(12):2285-9. PubMed ID: 25131941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endocrine sequelae after treatment of pediatric cancer: From childhood to adulthood].
    Thomas-Teinturier C; Salenave S
    Bull Cancer; 2015; 102(7-8):612-21. PubMed ID: 25981322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up.
    Karavitaki N; Brufani C; Warner JT; Adams CB; Richards P; Ansorge O; Shine B; Turner HE; Wass JA
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):397-409. PubMed ID: 15807869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Final height and weight of long-term survivors of childhood malignancies.
    Müller HL; Klinkhammer-Schalke M; Kühl J
    Exp Clin Endocrinol Diabetes; 1998; 106(2):135-9. PubMed ID: 9628245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Growth hormone treatment in childhood cancer survivors].
    Sampaio M; Oliveira A; Soro I; Costa C; Castro-Correia C; Fontoura M
    Acta Med Port; 2011 Dec; 24 Suppl 2():393-8. PubMed ID: 22849927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic endocrine testing and magnetic resonance imaging in the long-term follow-up of childhood langerhans cell histiocytosis.
    Maghnie M; Bossi G; Klersy C; Cosi G; Genovese E; Aricò M
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3089-94. PubMed ID: 9745408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine complications and components of the metabolic syndrome in survivors of childhood malignant non-brain solid tumors.
    Shalitin S; Laur E; Lebenthal Y; Ash S; Yaniv I; Phillip M
    Horm Res Paediatr; 2014; 81(1):32-42. PubMed ID: 24246763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine and growth features in childhood craniopharyngioma: a mono-institutional study.
    Di Battista E; Naselli A; Queirolo S; Gallarotti F; Garré ML; Milanaccio C; Cama A
    J Pediatr Endocrinol Metab; 2006 Apr; 19 Suppl 1():431-7. PubMed ID: 16700321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine outcome in long-term survivors of childhood brain tumors.
    Shalitin S; Gal M; Goshen Y; Cohen I; Yaniv I; Phillip M
    Horm Res Paediatr; 2011; 76(2):113-22. PubMed ID: 21691048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early endocrine complications in childhood cancer survivors].
    Sánchez González C; Andrades Toledo M; Cárdeno Morales Á; Gutiérrez Carrasco I; Ramírez Villar GL; Pérez Hurtado JM; García García E
    Med Clin (Barc); 2016 Oct; 147(8):329-333. PubMed ID: 27450178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine sequelae beyond 10 years in survivors of medulloblastoma.
    Uday S; Murray RD; Picton S; Chumas P; Raju M; Chandwani M; Alvi S
    Clin Endocrinol (Oxf); 2015 Nov; 83(5):663-70. PubMed ID: 25952583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrinological outcome of different treatment options in children with craniopharyngioma: a retrospective analysis of 66 cases.
    Gonc EN; Yordam N; Ozon A; Alikasifoglu A; Kandemir N
    Pediatr Neurosurg; 2004; 40(3):112-9. PubMed ID: 15367800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth and endocrine sequelae of craniopharyngioma.
    DeVile CJ; Grant DB; Hayward RD; Stanhope R
    Arch Dis Child; 1996 Aug; 75(2):108-14. PubMed ID: 8869189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study.
    Brownstein CM; Mertens AC; Mitby PA; Stovall M; Qin J; Heller G; Robison LL; Sklar CA
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4422-7. PubMed ID: 15356041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours.
    Gleeson HK; Shalet SM
    Endocr Relat Cancer; 2004 Dec; 11(4):589-602. PubMed ID: 15613441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrinological late effects of oncologic treatment on survivors of medulloblastoma.
    Hidalgo Santos AD; de Mingo Alemany MDC; Moreno Macián F; León Cariñena S; Collado Ballesteros E; Cañete Nieto A
    Rev Chil Pediatr; 2019 Dec; 90(6):598-605. PubMed ID: 32186582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early and late endocrine effects in pediatric central nervous system diseases.
    Aslan IR; Cheung CC
    J Pediatr Rehabil Med; 2014; 7(4):281-94. PubMed ID: 25547881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.